Annals of Hematology

, Volume 92, Issue 1, pp 125–127 | Cite as

Use of targeted therapy for refractory ALK-positive anaplastic large cell lymphoma as a bridging strategy prior to allogeneic transplantation

  • R. Ordemann
  • J. Stöhlmacher
  • B. Beuthien-Baumann
  • I. Platzek
  • J. van den Hoff
  • F. Kroschinsky
  • J. M. Middeke
  • U. Platzbecker
  • C. Zietz
  • M. Bornhäuser
  • G. Ehninger
Letter to the Editor

References

  1. 1.
    Gambacorti-Passerini C, Messa C, Pogliani EM (2011) Crizotinib in anaplastic large-cell lymphoma. N Engl J Med 364:775–776PubMedCrossRefGoogle Scholar
  2. 2.
    Kwak EL, Bang YJ, Camidge DR, Shaw AT et al (2010) Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 363:1693–1703PubMedCrossRefGoogle Scholar
  3. 3.
    Shaw AT, Yeap BY, Solomon BJ, Riely GJ et al (2011) Effect of Crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis. Lancet Oncol 11:1004–1012CrossRefGoogle Scholar
  4. 4.
    Younes A, Bartelett NL, Leonard JP, Kennedy DA et al (2010) Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. N Engl J Med 363:1812–1821PubMedCrossRefGoogle Scholar
  5. 5.
    Van Besien K (2011) Current status of allogeneic transplantation for aggressive non-Hodgkin lymphoma. Curr Opin Oncol 23:681–691PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • R. Ordemann
    • 1
  • J. Stöhlmacher
    • 1
  • B. Beuthien-Baumann
    • 2
  • I. Platzek
    • 2
  • J. van den Hoff
    • 3
  • F. Kroschinsky
    • 1
  • J. M. Middeke
    • 1
  • U. Platzbecker
    • 1
  • C. Zietz
    • 4
  • M. Bornhäuser
    • 1
  • G. Ehninger
    • 1
  1. 1.Medical Clinic and Policlinic IUniversity HospitalDresdenGermany
  2. 2.Department of Radiation OncologyUniversity HospitalDresdenGermany
  3. 3.PET CenterInstitute of Radiopharmacy, Helmholtz-Zentrum Dresden-RossendorfDresdenGermany
  4. 4.Department of PathologyUniversity HospitalDresdenGermany

Personalised recommendations